Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Zimmer Biomet Holdings, Inc. before investing.
In this article, we go over a few key elements for understanding Zimmer Biomet Holdings, Inc.’s stock price such as:
- Zimmer Biomet Holdings, Inc.’s current stock price and volume
- Why Zimmer Biomet Holdings, Inc.’s stock price changed recently
- Upgrades and downgrades for ZBH from analysts
- ZBH’s stock price momentum as measured by its relative strength
About Zimmer Biomet Holdings, Inc. (ZBH)
Before we jump into Zimmer Biomet Holdings, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company’s products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Want to learn more about Zimmer Biomet Holdings, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Zimmer Biomet Holdings, Inc..
Zimmer Biomet Holdings, Inc.’s Stock Price as of Market Close
As of July 31, 2026, 4:00 PM, CST, Zimmer Biomet Holdings, Inc.’s stock price was $93.930.
Zimmer Biomet Holdings, Inc. is down 1.08% from its previous closing price of $94.960.
During the last market session, Zimmer Biomet Holdings, Inc.’s stock traded between $91.070 and $94.280. Currently, there are approximately 195.00 million shares outstanding for Zimmer Biomet Holdings, Inc..
Zimmer Biomet Holdings, Inc.’s price-earnings (P/E) ratio is currently at 24.4, which is low compared to the Health Care Equipment & Supplies industry median of 31.1. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.
Zimmer Biomet Holdings, Inc. Stock Price History
Zimmer Biomet Holdings, Inc.’s (ZBH) price is currently up 9.11% so far this month.
During the month of July, Zimmer Biomet Holdings, Inc.’s stock price has reached a high of $97.600 and a low of $84.070.
Over the last year, Zimmer Biomet Holdings, Inc. has hit prices as high as $108.290 and as low as $79.120. Year to date, Zimmer Biomet Holdings, Inc.’s stock is up 4.46%.
Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions
What Caused Zimmer Biomet Holdings, Inc. Stock’s Price to Dip?
Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?
When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there was 1 analyst who downgraded Zimmer Biomet Holdings, Inc.’s stock and 0 analysts who upgraded over the last month.
Additionally, you'll want to evaluate Zimmer Biomet Holdings, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Zimmer Biomet Holdings, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.
Zimmer Biomet Holdings, Inc.’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.
Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.
Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Zimmer Biomet Holdings, Inc. (ZBH) by visiting AAII Stock Evaluator.
Relative Price Strength of Zimmer Biomet Holdings, Inc.
Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.
For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.
As of July 31, 2026, Zimmer Biomet Holdings, Inc. has a weighted four-quarter relative price strength of -0.63%, which translates to a Momentum Score of 51 and is considered to be Average.
Want to learn more about how Zimmer Biomet Holdings, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.
Zimmer Biomet Holdings, Inc. Stock Price: Bottom Line
As of July 31, 2026, Zimmer Biomet Holdings, Inc.’s stock price is $93.930, which is down 1.08% from its previous closing price.
AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Zimmer Biomet Holdings, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.
Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.
Included With AAII Platinum
at only 23.3%
Since Inception. Data as of 12/31/2024.
769.3% Stock Superstars Portfolio Total Return Since Inception
U.S. Index ETF (IYY)
SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.
FREE REPORT
BECOME A MEMBER FOR ONLY $2
Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.